HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ezra E W Cohen Selected Research

Neoplasm Metastasis (Metastasis)

1/2021Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
6/2012Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
5/2010New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors.
12/2004Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ezra E W Cohen Research Topics

Disease

70Neoplasms (Cancer)
03/2022 - 05/2003
56Squamous Cell Carcinoma of Head and Neck
03/2022 - 05/2003
36Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 05/2004
9Thyroid Neoplasms (Thyroid Cancer)
12/2015 - 05/2006
7Exanthema (Rash)
10/2019 - 09/2012
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2015 - 10/2002
6Fatigue
12/2019 - 10/2010
4Neoplasm Metastasis (Metastasis)
01/2021 - 12/2004
4Stomatitis
10/2019 - 05/2015
4Nausea
10/2019 - 10/2010
4Diarrhea
10/2019 - 06/2013
4medullary Thyroid cancer
12/2016 - 07/2011
4Mucositis
10/2013 - 10/2010
3Hemorrhage
10/2020 - 04/2008
3Melanoma (Melanoma, Malignant)
10/2020 - 12/2014
3Disease Progression
01/2020 - 03/2009
3Papillary Thyroid Cancer
09/2016 - 04/2012
3Mouth Neoplasms (Oral Cancer)
02/2016 - 05/2010
3Neutropenia
05/2015 - 04/2008
2Carcinoma (Carcinomatosis)
03/2022 - 01/2020
2Inflammation (Inflammations)
01/2022 - 11/2016
2Salivary Gland Neoplasms (Salivary Gland Cancer)
01/2020 - 07/2011
2Pneumonia (Pneumonitis)
12/2019 - 06/2014
2Acne Vulgaris
10/2019 - 05/2015
2Osteoradionecrosis
01/2010 - 07/2008
2Fistula
07/2008 - 04/2008
2Necrosis
07/2008 - 04/2008
2Hypoxia (Hypoxemia)
06/2008 - 12/2004
2Carcinogenesis
04/2008 - 12/2006
1Tertiary Lymphoid Structures
11/2021

Drug/Important Bio-Agent (IBA)

18ErbB Receptors (EGF Receptor)IBA
02/2016 - 05/2003
12PlatinumIBA
01/2021 - 05/2011
10Biomarkers (Surrogate Marker)IBA
12/2019 - 05/2011
9pembrolizumabIBA
03/2022 - 01/2019
9Cetuximab (Erbitux)FDA Link
01/2021 - 02/2010
9Gefitinib (Iressa)FDA Link
06/2013 - 05/2003
8Pharmaceutical PreparationsIBA
01/2022 - 06/2013
8IodineIBA
09/2016 - 05/2006
8Tyrosine Kinase InhibitorsIBA
05/2015 - 11/2005
7Cisplatin (Platino)FDA LinkGeneric
01/2020 - 03/2007
7Bevacizumab (Avastin)FDA Link
01/2019 - 04/2008
6Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
6AfatinibIBA
10/2019 - 06/2013
6Axitinib (AG 013736)IBA
04/2015 - 10/2008
5Phosphotransferases (Kinase)IBA
01/2020 - 11/2005
5Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2016 - 06/2008
4Peptides (Polypeptides)IBA
01/2022 - 01/2016
4AntibodiesIBA
01/2022 - 12/2019
4Methotrexate (Mexate)FDA LinkGeneric
12/2019 - 04/2009
4Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 04/2008
4cabozantinibIBA
12/2016 - 07/2011
3Immunoconjugates (Immunoconjugate)IBA
01/2022 - 01/2020
3RNA (Ribonucleic Acid)IBA
01/2020 - 02/2010
3LigandsIBA
12/2019 - 02/2010
3Carboplatin (JM8)FDA LinkGeneric
08/2019 - 10/2002
3Sirolimus (Rapamycin)FDA Link
01/2018 - 04/2011
3Hydroxyurea (Hydrea)FDA LinkGeneric
01/2016 - 04/2008
3Biological ProductsIBA
01/2016 - 04/2012
3Proteins (Proteins, Gene)FDA Link
01/2016 - 06/2006
3Sunitinib (Sutent)FDA Link
11/2015 - 10/2010
3DNA (Deoxyribonucleic Acid)IBA
08/2015 - 01/2009
2auristatinIBA
01/2022 - 01/2020
2AntigensIBA
01/2021 - 01/2019
2MTOR InhibitorsIBA
01/2021 - 01/2019
2NivolumabIBA
05/2020 - 01/2019
2Monoclonal AntibodiesIBA
12/2019 - 12/2006
2Docetaxel (Taxotere)FDA Link
12/2019 - 09/2007
2Metformin (Glucophage)FDA LinkGeneric
01/2019 - 01/2018
2CytokinesIBA
01/2018 - 11/2016
2Paclitaxel (Taxol)FDA LinkGeneric
01/2016 - 12/2004
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2015 - 12/2006
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2014 - 10/2008
2Iodine-131IBA
01/2014 - 04/2012
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2013 - 05/2012
2Proto-Oncogene Proteins c-metIBA
10/2013 - 04/2009
2Sorafenib (BAY 43-9006)FDA Link
01/2013 - 04/2011
2Lapatinib (GW572016)FDA Link
04/2012 - 08/2009
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2009 - 04/2008
1Agammaglobulinaemia Tyrosine KinaseIBA
03/2022
1acalabrutinibIBA
03/2022
1Toll-Like Receptor 9IBA
01/2022
1monomethyl auristatin EIBA
01/2022
1B7-H1 AntigenIBA
01/2021
1Cancer VaccinesIBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1VaccinesIBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1EverolimusFDA Link
01/2021
1talimogene laherparepvecIBA
10/2020

Therapy/Procedure

40Therapeutics
03/2022 - 10/2002
21Drug Therapy (Chemotherapy)
01/2021 - 05/2004
19Radiotherapy
01/2020 - 10/2002
18Chemoradiotherapy
01/2020 - 07/2006
15Immunotherapy
01/2022 - 01/2008
8Induction Chemotherapy
01/2016 - 02/2004
4Re-Irradiation
10/2011 - 03/2007
2Drug Tapering
10/2013 - 10/2010
2Laryngectomy
10/2012 - 07/2012
2Dental Care
05/2012 - 05/2010
2Adjuvant Chemoradiotherapy
07/2011 - 08/2009